Myotonic Dystrophy Type 2: Clinical and Genetic Aspects

Genetic Instabilities and Neurological Diseases

Volumn , Issue , 2006, Pages 131-150

  Krahe, Ralf ^a   Bachinski, Linda L ^a   Udd, Bjarne ^b,c  

^a UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

^b TAMPERE UNIVERSITY OF TECHNOLOGY   (Finland)

^c UNIVERSITY OF HELSINKI   (Finland)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 62549109350     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1016/B978-012369462-1/50009-0     Document Type: Chapter

References (161)

1. Harper P.S. Myotonic Dystrophy 2001, Saunders, London.
2. Brook J.D., McCurrach M.E., Harley H.G., Buckler A.J., Church D., Aburatani H., Hunter K., Stanton V.P., Thirion J.P., Hudson T., Sohn R., Zemelman B., Snell R.S., Rundle S.A., Crow S., Davies J., Shelbourne P., Buxton J., Jones C., Juvonen V., Johnson K., Harper P.S., Shaw D.J., Housman D.E. Molecular basis of myotonic dystrophy: Expansion of a trinucleotide (CTG) repeat at the 3? end of a transcript encoding a protein kinase family member. Cell 1992, 68:799-808.
3. Fu Y.H., Pizzuti A., Fenwick R.G., King J., Rajnarayan S., Dunne P.W., Dubel J., Nasser G.A., Ashizawa T., de Jong P., Wieringa B., Korneluk R., Perryman M.B., Epstein H.F., Caskey C.T. An unstable triplet repeat in a gene related to myotonic muscular dystrophy. Science 1992, 255:1256-1258.
4. Mahadevan M., Tsilfidis C., Sabourin L., Shutler G., Amemiya C., Jansen G., Neville C., Narang M., Barcelo J., O'Hoy K., Leblond S., Earle-Macdonald J., de Jong P., Wierenga B., Korneluk R.G. Myotonic dystrophy mutation: An unstable CTG repeat in the 3? untranslated region of the gene. Science 1992, 255:1253-1255.
5. Ricker K., Koch M.C., Lehmann-Horn F., Pongratz D., Otto M., Heine R., Moxley R.T. Proximal myotonic myopathy: A new dominant disorder with myotonia, muscle weakness, and cataracts. Neurology 1994, 44:1448-1452.
6. Thornton C.A., Griggs R.C., Moxley R.T. Myotonic dystrophy with no trinucleotide repeat expansion. Ann. Neurol. 1994, 35:269-272.
7. Moxley R.T., Udd B., Ricker K. 54th ENMC International Workshop: PROMM (proximal myotonic myopathies) and other proximal myotonic syndromes. Neuromuscul. Disord. 1998, 8:508-518.
8. Abdalla J.A., Casley W.L., Cousin H.K., Hudson A.J., Murphy E.G., Cornelis F.C., Hashimoto L., Ebers G.C. Linkage of Thomsen disease to the T-cell-receptor beta (TCRB) locus on chromosome 7q35. Am. J. Hum. Genet. 1992, 51:579-584.
9. McClatchey A.I., Trofatter J., McKenna-Yasek D., Raskind W., Bird T., Pericak-Vance M., Gilchrist J., Arahata K., Radosavljevic D., Worthen H.G., et al. Dinucleotide repeat polymorphisms at the SCN4A locus suggest allelic heterogeneity of hyperkalemic periodic paralysis and paramyotonia congenita. Am. J. Hum. Genet. 1992, 50:896-901. [published erratum appears in Am J Hum Genet 1992 Oct; 51(4):942] [see comments].
10. Lacomis D., Chad D.A., Smith T.W. Proximal weakness as the primary manifestation of myotonic dystrophy in older adults [see comments]. Muscle Nerve 1994, 17:687-688.
11. Ricker K., Koch M.C., Lehmann-Horn F., Pongratz D., Speich N., Reiners K., Schneider C., Moxley R.T. Proximal myotonic myopathy: Clinical features of a multisystem disorder similar to myotonic dystrophy. Arch. Neurol. 1995, 52:25-31.
12. Stoll G., von Giesen H.J., Koch M.C., Arendt G., Benecke R. Proximal myotonic myopathy syndrome in the absence of trinucleotide repeat expansions. Muscle Nerve 1995, 18:782-783.
13. Hund E., Jansen O., Koch M.C., Ricker K., Fogel W., Niedermaier N., Otto M., Kuhn E., Meinck H.M. Proximal myotonic myopathy with MRI white matter abnormalities of the brain. Neurology 1997, 48:33-37.
14. Meola G., Sansone V., Radice S., Skradski S., Ptacek L. A family with an unusual myotonic and myopathic phenotype and no CTG expansion (proximal myotonic myopathy syndrome): A challenge for future molecular studies. Neuromuscul. Disord. 1996, 6:143-150.
15. Gamez J., Cervera C., Fernandez J., Martinez J., Martorell L., Teijeira S., Navarro C. Proximal myotonic myopathy report of three families [abstract]. Neuromuscul. Disord. 1996, 6(Suppl.):S46.
16. Sansone V., Cappa S., Cotelli C., Rognone F., Thornton C.A., Moxley R.T. Magnetic resonance imaging and cognitive alterations in proximal myotonic myopathy (PROMM). Neurology 1997, 48(Suppl.):A231.
17. Rowland L.P. Thornton-Griggs-Moxley disease: Myotonic dystrophy type 2 [letter]. Ann. Neurol. 1994, 36:803-804.
18. Sander H.W., Tavoulareas G.P., Chokroverty S. Heat-sensitive myotonia in proximal myotonic myopathy. Neurology 1996, 47:956-962.
19. Griggs R., Sansone V., Lifton A., Moxley R.T. Hypothyroidism unmasking proximal myotonic myopathy (PROMM). Neurology 1997, 48(Suppl.):A267.
20. Moxley R.T., Sansone V., Lifton A., Thornton C.A. Insulin resistance in proximal myotonic myopathy (PROMM). Neurology 1997, 48(Suppl.):A229.
21. Udd B., Krahe R., Wallgren-Pettersson C., Falck B., Kalimo H. Proximal myotonic dystrophy-a family with autosomal dominant muscular dystrophy, cataracts, hearing loss and hypogonadism: Heterogeneity of proximal myotonic syndromes?. Neuromuscul. Disord. 1997, 7:217-228.
22. Day J.W., Roelofs R., Leroy B., Pech I., Benzow K., Ranum L.P. Clinical and genetic characteristics of a five-generation family with a novel form of myotonic dystrophy (DM2). Neuromuscul. Disord. 1999, 9:19-27.
23. Ranum L.P., Rasmussen P.F., Benzow K.A., Koob M.D., Day J.W. Genetic mapping of a second myotonic dystrophy locus. Nat. Genet. 1998, 19:196-198.
24. Ricker K., Grimm T., Koch M.C., Schneider C., Kress W., Reimers C.D., Schulte-Mattler W., Mueller-Myhsok B., Toyka K.V., Mueller C.R. Linkage of proximal myotonic myopathy to chromosome 3q. Neurology 1999, 52:170-171.
25. Meola G., Udd B., Sansone V., Ptacek L., Lee D., Krahe R. Dominant multi-system proximal myotonic myopathy syndromes: Clinical and genetic heterogeneity in three families. Neurology 1999, 52(Suppl.):A95.
26. Moxley R.T., Meola G., Udd B., Ricker K. Report of the 84th ENMC Workshop: PROMM (Proximal Myotonic Myopathy) and Other Myotonic Dystrophy-Like Syndromes: 2nd Workshop. Neuromuscul. Disord. 2002, 12:306-317.
27. International-Myotonic-Dystrophy-Consortium New nomenclature and DNA testing guidelines for myotonic dystrophy type 1 (DM1). Neurology 2000, 54:1218-1221.
28. Liquori C.L., Ricker K., Moseley M.L., Jacobsen J.F., Kress W., Naylor S.L., Day J.W., Ranum L.P. Myotonic dystrophy type 2 caused by a CCTG expansion in intron 1 of ZNF9. Science 2001, 293:864-867.
29. n expansion mutation in patients with proximal myotonic myopathy/proximal myotonic dystrophy of different European origins: A single shared haplotype indicates an ancestral founder effect. Am. J. Hum. Genet. 2003, 73:835-848.
30. Liquori C.L., Ikeda Y., Weatherspoon M., Ricker K., Schoser B.G., Dalton J.C., Day J.W., Ranum L.P. Myotonic dystrophy type 2: Human founder haplotype and evolutionary conservation of the repeat tract. Am. J. Hum. Genet. 2003, 73:849-862.
31. Udd B., Meola G., Krahe R., Thornton C., Ranum L., Day J., Bassez G., Ricker K. Report of the 115th ENMC workshop: DM2/PROMM and other myotonic dystrophies. 3rd Workshop. Neuromuscul. Disord. 2003, 13:589-596.
32. Kress W., Mueller-Myhsok B., Ricker K., Schneider C., Koch M.C., Toyka K.V., Mueller C.R., Grimm T. Proof of genetic heterogeneity in the proximal myotonic myopathy syndrome (PROMM) and its relationship to myotonic dystrophy type 2 (DM2). Neuromuscul. Disord. 2000, 10:478-480.
33. Sun C., Henriksen O.A., Tranebjaerg L. Proximal myotonic myopathy: Clinical and molecular investigation of a Norwegian family with PROMM. Clin. Genet. 1999, 56:457-461.
34. Wieser R., Volz A., Vinatzer U., Gardiner K., Jager U., Mitterbauer M., Ziegler A., Fonatsch C. Transcription factor GATA-2 gene is located near 3q21 breakpoints in myeloid leukemia. Biochem. Biophys. Res. Commun. 2000, 273:239-245.
35. Day J.W., Ricker K., Jacobsen J.F., Rasmussen L.J., Dick K.A., Kress W., Schneider C., Koch M.C., Beilman G.J., Harrison A.R., Dalton J.C., Ranum L.P. Myotonic dystrophy type 2: Molecular, diagnostic and clinical spectrum. Neurology 2003, 60:657-664.
36. George A., Schneider-Gold C., Zier S., Reiners K., Sommer C. Musculoskeletal pain in patients with myotonic dystrophy type 2. Arch. Neurol. 2004, 61:1938-1942.
37. Meola G., Sansone V., Perani D., Scarone S., Cappa S., Dragoni C., Cattaneo E., Cotelli M., Gobbo C., Fazio F., Siciliano G., Mancuso M., Vitelli E., Zhang S., Krahe R., Moxley R.T. Executive dysfunction and avoidant personality trait in myotonic dystrophy type 1 (DM-1) and in proximal myotonic myopathy (PROMM/DM-2). Neuromuscul. Disord. 2003, 13:813-821.
38. Kassubek J., Juengling F.D., Hoffmann S., Rosenbohm A., Kurt A., Jurkat-Rott K., Steinbach P., Wolf M., Ludolph A.C., Lehmann-Horn F., Lerche H., Weber Y.G. Quantification of brain atrophy in patients with myotonic dystrophy and proximal myotonic myopathy: A controlled 3-dimensional magnetic resonance imaging study. Neurosci. Lett. 2003, 348:73-76.
39. Kornblum C., Reul J., Kress W., Grothe C., Amanatidis N., Klockgether T., Schroder R. Cranial magnetic resonance imaging in genetically proven myotonic dystrophy type 1 and 2. J. Neurol. 2004, 251:710-714.
40. 31P-MRS and MRI study. Muscle Nerve 2004, 30:636-644.
41. Schoser B.G., Ricker K., Schneider-Gold C., Hengstenberg C., Durre J., Bultmann B., Kress W., Day J.W., Ranum L.P. Sudden cardiac death in myotonic dystrophy type 2. Neurology 2004, 63:2402-2404.
42. Newman B., Meola G., O'Donovan D.G., Schapira A.H., Kingston H. Proximal myotonic myopathy (PROMM) presenting as myotonia during pregnancy. Neuromuscul. Disord. 1999, 9:144-149.
43. Grewal R.P., Zhang S., Ma W., Rosenberg M., Krahe R. Clinical and genetic analysis of a family with PROMM. J. Clin. Neurosci. 2004, 11:603-605.
44. Chu K., Cho J.W., Song E.C., Jeon B.S. A patient with proximal myotonic myopathy and parkinsonism. Can. J. Neurol. Sci. 2002, 29:188-190.
45. Schneider C., Pedrosa Gil F., Schneider M., Anetseder M., Kress W., Muller C.R. Intolerance to neuroleptics and susceptibility for malignant hyperthermia in a patient with proximal myotonic myopathy (PROMM) and schizophrenia. Neuromuscul. Disord. 2002, 12:31-35.
46. Merlini L., Sabatelli P., Columbaro M., Bonifazi E., Pisani V., Massa R., Novelli G. Hyper-CK-emia as the sole manifestation of myotonic dystrophy type 2. Muscle Nerve 2005, 31:764-767.
47. Harley H.G., Rundle S.A., Reardon W., Myring J., Crow S., Brook J.D., Harper P.S., Shaw D.J. Unstable DNA sequence in myotonic dystrophy. Lancet 1992, 339:1125-1128.
48. Lavedan C., Hofmann-Radvanyi H., Shelbourne P., Rabes J.P., Savoy D., Dehaupas I., Luce S., Johnson K., Junien C. Myotonic dystrophy: Size- and sex-dependent dynamics of CTG instability, and somatic mosaicism. Am. J. Hum. Genet. 1993, 52:875-883.
49. Ashizawa T., Dubel J.R., Dunne P.W., Dunne C.J., Fu Y.-H., Caskey C.T., Boerwinkle E., Perryman M.B., Epstein H.F., Hejtmancik J.F. Anticipation in myotonic dystrophy: II. Complex relationships between clinical findings and structure of the GCT repeat. Neurology 1992, 42:1877-1883.
50. Ashizawa T., Dunne C.J., Dubel J.M., Perryman M.B., Boerwinkle E., Hejtmancik J.F. Anticipation in myotonic dystrophy: I. Statistical verification based on clinical and haplotype findings. Neurology 1992, 42:1871-1877.
51. Barcelo J.M., Mahadevan M.S., Tsilfidis C., MacKenzie A.E., Korneluk R.G. Intergenerational stability of the myotonic dystrophy. Hum. Mol. Genet. 1993, 2:705-709.
52. Ashizawa T., Dunne P.W., Ward P.A., Seltzer W.K., Richards C.S. Effects of sex of myotonic dystrophy patients on the unstable triplet repeat in their affected offspring. Neurology 1994, 44:120-122.
53. Ashizawa T., Anvret M., Baiget M., Barcelo J.M., Brunner H., Cobo A.M., Dallapiccola B., Fenwick R.G., Grandell U., Harley H., Junien C., Koch M.C., Korneluk R.G., Lavedan C., Miki T., Muley J.C., Lopez de Munain A., Novelli G., Roses A.D., Seltzer W.K., Shaw D.J., Smeets H., Sutherland G.R., Yamagata H., Harper P.S. Characteristics of intergenerational contractions of the CTG repeat in myotonic dystrophy. Am. J. Hum. Genet. 1994, 54:414-423.
54. Hamshere M.G., Harley H., Harper P., Brook J.D., Brookfield J.F. Myotonic dystrophy: The correlation of (CTG) repeat length in leucocytes with age at onset is significant only for patients with small expansions. J. Med. Genet. 1999, 36:59-61.
55. Tsilfidis C., MacKenzie A.E., Mettler G., Barcelo J., Korneluk R.G. Correlation between CTG trinucleotide repeat length and frequency of severe congenital myotonic dystrophy. Nat. Genet. 1992, 1:192-195.
56. Logigian E.L., Moxley R.T., Blood C.L., Barbieri C.A., Martens W.B., Wiegner A.W., Thornton C.A. Leukocyte CTG repeat length correlates with severity of myotonia in myotonic dystrophy type 1. Neurology 2004, 62:1081-1089.
57. Schneider C., Ziegler A., Ricker K., Grimm T., Kress W., Reimers C.D., Meinck H., Reiners K., Toyka K.V. Proximal myotonic myopathy: Evidence for anticipation in families with linkage to chromosome 3q. Neurology 2000, 55:383-388.
58. Tsilfidis C., MacKenzie A.E., Mettler G., Barcelo J. Correlation between CTG trinucleotide repeat length and severe congenital myotonic dystrophy. Nat. Genet. 1992, 1:192-195.
59. Monckton D.G., Wong L.J., Ashizawa T., Caskey C.T. Somatic mosaicism, germline expansions, germline reversions and intergenerational reductions in myotonic dystrophy males: Small pool PCR analyses. Hum. Mol. Genet. 1995, 4:1-8.
60. Schoser B.G., Kress W., Walter M.C., Halliger-Keller B., Lochmuller H., Ricker K. Homozygosity for CCTG mutation in myotonic dystrophy type 2. Brain 2004, 127:1868-1877.
61. Bassez G., Attarian S., Laforet P., Azulay J.P., Rouche A., Ferrer X., Urtizberea J.A., Pellissier J.F., Duboc D., Fardeau M., Pouget J., Eymard B. Proximal myotonial myopathy (PROMM): Clinical and histology study. Rev. Neurol. (Paris) 2001, 157:209-218.
62. Vihola A., Bassez G., Meola G., Zhang S., Haapasalo H., Paetau A., Mancinelli E., Rouche A., Hogrel J.Y., Laforet P., Maisonobe T., Pellissier J.F., Krahe R., Eymard B., Udd B. Histopathological differences of myotonic dystrophy type 1 (DM1) and PROMM/DM2. Neurology 2003, 60:1854-1857.
63. Schoser B.G., Schneider-Gold C., Kress W., Goebel H.H., Reilich P., Koch M.C., Pongratz D.E., Toyka K.V., Lochmuller H., Ricker K. Muscle pathology in 57 patients with myotonic dystrophy type 2. Muscle Nerve 2004, 29:275-281.
64. Richards R.I. Dynamic mutations: A decade of unstable expanded repeats in human genetic disease. Hum. Mol. Genet. 2001, 10:2187-2194.
65. Richards R.I., Sutherland G.R. Dynamic mutations: A new class of mutations causing human. Cell 1992, 70:709-712.
66. Ashley C.T., Warren S.T. Trinucleotide repeat expansion and human disease. Annu. Rev. Genet. 1995, 29:703-728.
67. Ashizawa T., Epstein H.F. Ethnic distribution of myotonic dystrophy gene. Lancet 1991, 338:642-643.
68. Imbert G., Kretz C., Johnson K., Mandel J.L. Origin of the expansion mutation in myotonic dystrophy. Nat. Genet. 1993, 4:72-76.
69. Neville C.E., Mahadevan M.S., Barcelo J.M., Korneluk R.G. High resolution genetic analysis suggests one ancestral predisposing haplotype for the origin of the myotonic dystrophy mutation. Hum. Mol. Genet. 1994, 3:45-51.
70. Yamagata H., Miki T., Nakagawa M., Johnson K., Deka R., Ogihara T. Association of CTG repeats and the 1-kb Alu insertion/deletion polymorphism at the myotonin protein kinase gene in the Japanese population suggests a common Eurasian origin of the myotonic dystrophy mutation. Hum. Genet. 1996, 97:145-147.
71. Krahe R., Eckhart M., Ogunniyi A.O., Osuntokun B.O., Siciliano M.J., Ashizawa T. De novo myotonic dystrophy mutation in a Nigerian kindred. Am. J. Hum. Genet. 1995, 56:1067-1074.
72. Mahadevan M.S., Foitzik M.A., Surh L.C., Korneluk R.G. Characterization and polymerase chain reaction (PCR) detection Alu deletion polymorphism in total linkage disequilibrium with myotonic dystrophy. Genomics 1993, 15:446-448.
73. Yamagata H., Miki T., Ogihara T., Nakagawa M., Higuchi I., Shelbourne P., Davies J., Johnson K. Expansion of unstable DNA region in Japanese myotonic dystrophy patients. Lancet 1992, 339:692.
74. Yamagata H., Miki T., Yamanaka N., Takemoto Y., Kanda F., Takahashi K., Inui T., Kinoshita M., Nakagawa M., Higuchi I., Osame M., Ogihara T. Characteristics of dynamic mutation in Japanese myotonic dystrophy. Jpn. J. Hum. Genet. 1994.
75. Yamagata H., Miki T., Sakoda S.-I., Yamanaka N., Davies J., Shelbourne P., Kubota R., Takenaga S., Nakagawa M., Ogihara T., Johnson K. Detection of a premutation in Japanese myotonic dystrophy. Hum. Mol. Genet. 1994, 3:819-820.
76. Davies J., Yamagata H., Shelbourne P., Buxton J., Ogihara T., Nokelainen P., Nakagawa M., Williamson R., Johnson K., Miki T. Comparison of the myotonic dystrophy associated CTG repeat in European and Japanese populations. J. Med. Genet. 1992, 29:766-769.
77. Goldman A., Ramsay M., Jenkins T. Absence of myotonic dystrophy in southern African Negroids is associated with a significantly lower number of CTG trinucleotide repeats. J. Med. Genet. 1994, 31:37-40.
78. Goldman A., Ramsay M., Jenkins T. New founder haplotypes at the myotonic dystrophy locus in southern Africa. Am. J. Hum. Genet. 1995, 56:1373-1378.
79. Goldman A., Ramsay M., Jenkins T. Ethnicity and myotonic dystrophy: A possible explanation for its absence in sub-Saharan Africa. Ann. Hum. Genet. 1996, 60:57-65.
80. Yamagata H., Nakagawa M., Johnson K., Miki T. Further evidence for a major ancient mutation underlying myotonic dystrophy from linkage disequilibrium studies in the Japanese population. J. Hum. Genet. 1998, 43:246-249.
81. Brock G.J., Anderson N.H., Monckton D.G. cis-acting modifiers of expanded CAG CTG triplet repeat expandability: Associations with flanking GC content and proximity to CpG islands. Hum. Mol. Genet. 1999, 8:1061-1067.
82. Richards R.I., Crawford J., Narahara K., Mangelsdorf M., Friend K., Staples A., Denton M., Easteal S., Hori T.A., Kondo I., Jenkins T., Goldman A., Panich V., Ferakova E., Sutherland G.R. Dynamic mutation loci: Allele distributions in different populations. Ann. Hum. Genet. 1996, 60:391-400.
83. Cleary J.D., Nichol K., Wang Y.H., Pearson C.E. Evidence of cis-acting factors in replication-mediated trinucleotide repeat instability in primate cells. Nat. Genet. 2002, 31:37-46.
84. Gourdon G., Radvanyi F., Lia A.S., Duros C., Blanche M., Abitbol M., Junien C., Hofmann-Radvanyi H. Moderate intergenerational and somatic instability of a 55-CTG repeat in transgenic mice. Nat. Genet. 1997, 15:190-192.
85. Monckton D.G., Coolbaugh M.I., Ashizawa K.T., Siciliano M.J., Caskey C.T. Hypermutable myotonic dystrophy CTG repeats in transgenic mice. Nat. Genet. 1997, 15:193-196.
86. Warner J.P., Barron L.H., Goudie D., Kelly K., Dow D., Fitzpatrick D.R., Brock D.J. A general method for the detection of large CAG repeat expansions by fluorescent PCR. J. Med. Genet. 1996, 33:1022-1026.
87. Sermon K., Seneca S., De Rycke M., Goossens V., Van de Velde H., De Vos A., Platteau P., Lissens W., Van Steirteghem A., Liebaers I. PGD in the lab for triplet repeat diseases: myotonic dystrophy, Huntington's disease and fragile-X syndrome. Mol. Cell. Endocrinol. 2001, 183(Suppl. 1):S77-S85.
88. Matsuura T., Ashizawa T. Polymerase chain reaction amplification of expanded ATTCT repeat in spinocerebellar ataxia type 10. Ann. Neurol. 2002, 51:271-272.
89. n mutation in myotonic dystrophy type 2 (DM2). Neuromuscul. Disord. 2004, 14:274-283.
90. n mutation in myotonic dystrophy type 2 (DM2) by FISH on muscle biopsy. Eur. J. Histochem. 2004, 48:437-442.
91. Meola G. Advanced microscopic and histochemical techniques: Diagnostic tools in the molecular era of myology. Eur. J. Histochem. 2005, 49:93-96.
92. Bonifazi E., Vallo L., Giardina E., Botta A., Novelli G. A long PCR-based molecular protocol for detecting normal and expanded ZNF9 alleles in myotonic dystrophy type 2. Diagn. Mol. Pathol. 2004, 13:164-166.
93. Jakubiczka S., Vielhaber S., Kress W., Kupferling P., Reuner U., Kunath B., Wieacker P. Improvement of the diagnostic procedure in proximal myotonic myopathy/myotonic dystrophy type 2. Neurogenetics 2004, 5:55-59.
94. Le Ber I., Martinez M., Campion D., Laquerriere A., Betard C., Bassez G., Girard C., Saugier-Veber P., Raux G., Sergeant N., Magnier P., Maisonobe T., Hennequin D. A non-DM1, non-DM2 multisystem myotonic disorder with frontotemporal dementia: Phenotype and suggestive mapping of the DM3 locus to chromosome 15q21-24. Brain 2004, 127:1979-1992.
95. Ranum L.P., Day J.W. Pathogenic RNA repeats: An expanding role in genetic disease. Trends Genet 2004, 20:506-512.
96. Day J.W., Ranum L.P. RNA pathogenesis of the myotonic dystrophies. Neuromuscul. Disord. 2005, 15:5-16.
97. Jin P., Warren S.T. Understanding the molecular basis of fragile X syndrome. Hum. Mol. Genet. 2000, 9:901-908.
98. Pandolfo M. Molecular genetics and pathogenesis of Friedreich ataxia. Neuromuscul. Disord. 1998, 8:409-415.
99. Ross C.A. Polyglutamine pathogenesis: Emergence of unifying mechanisms for Huntington's disease and related disorders. Neuron 2002, 35:819-822.
100. Timchenko L.T. Myotonic dystrophy: The role of RNA CUG triplet repeats. Am. J. Hum. Genet. 1999, 64:360-364.
101. Tapscott S.J. Deconstructing myotonic dystrophy. Science 2000, 289:1701-1702.
102. Krahe R., Ashizawa T., Abbruzzese C., Roeder E., Carango P., Giacanelli M., Funanage V.L., Siciliano M.J. Effect of myotonic dystrophy trinucleotide repeat expansion on DMPK transcription and processing. Genomics 1995, 28:1-14.
103. Jansen G., Groenen P.J., Bachner D., Jap P.H., Coerwinkel M., Oerlemans F., van den Broek W., Gohlsch B., Pette D., Plomp J.J., Molenaar P.C., Nederhoff M.G., van Echteld C.J., Dekker M., Berns A., Hameister H., Wieringa B. Abnormal myotonic dystrophy protein kinase levels produce only mild myopathy in mice [see comments]. Nat. Genet. 1996, 13:316-324.
104. Reddy S., Smith D.B., Rich M.M., Leferovich J.M., Reilly P., Davis B.M., Tran K., Rayburn H., Bronson R., Cros D., Balice-Gordon R.J., Housman D. Mice lacking the myotonic dystrophy protein kinase develop a late onset progressive myopathy. Nat. Genet. 1996, 13:325-335.
105. Berul C.I., Maguire C.T., Aronovitz M.J., Greenwood J., Miller C., Gehrmann J., Housman D., Mendelsohn M.E., Reddy S. DMPK dosage alterations result in atrioventricular conduction abnormalities in a mouse myotonic dystrophy model. J. Clin. Invest. 1999, 103:R1-R7.
106. Taneja K.L., McCurrach M., Schalling M., Housman D., Singer R.H. Foci of trinucleotide repeat transcripts in nuclei of myotonic dystrophy cells and tissues. J. Cell Biol. 1995, 128:995-1002.
107. Wang J., Pegoraro E., Menegazzo E., Gennarelli M., Hoop R.C., Angelini C., Hoffman E.P. Myotonic dystrophy: Evidence for a possible dominant-negative RNA mutation. Hum. Mol. Genet. 1995, 4:599-606.
108. Davis B.M., McCurrach M.E., Taneja K.L., Singer R.H., Housman D.E. Expansion of a CUG trinucleotide repeat in the 3? untranslated region of myotonic dystrophy protein kinase transcrips results in nuclear retention of transcripts. Proc. Nat. Acad. Sci. USA 1997, 94:7388-7393.
109. Koch K.S., Leffert H.L. Giant hairpins formed by CUG repeats in myotonic dystrophy messenger RNAs might sterically block RNA export through nuclear pores. J. Theor. Biol. 1998, 192:505-514.
110. Tiscornia G., Mahadevan M.S. Myotonic dystrophy: The role of the CUG triplet repeats in splicing of a novel DMPK exon and altered cytoplasmic DMPK mRNA isoform ratios. Mol. Cell 2000, 5:959-967.
111. Morrone A., Pegoraro E., Angelini C., Zammarchi E., Marconi G., Hoffman E.P. RNA metabolism in myotonic dystrophy: Patient muscle shows decreased insulin receptor RNA and protein consistent with abnormal insulin resistance. J. Clin. Invest. 1997, 99:1691-1698.
112. n repeat. Hum. Mol. Genet. 1995, 4:1919-1925.
113. Wang Y.-H., Amirhaeri S., Kang S., Wells R.D., Griffith J.D. Preferential nucleosome assembly at DNA triplet repeats from the myotonic dystrophy gene. Science 1994, 265:669-671.
114. Wang Y.-H., Griffith J. Expanded CTG triplet repeat blocks from the myotonic dystrophy gene create the strongest known natural nucleosome positioning element. Genomics 1995, 25:570-573.
115. Michalowski S., Miller J.W., Urbinati C.R., Paliouras M., Swanson M.S., Griffith J. Visualization of double-stranded RNAs from the myotonic dystrophy protein kinase gene and interactions with CUG-binding protein. Nucleic Acids Res. 1999, 27:3534-3542.
116. Klesert T.R., Otten A.D., Bird T.D., Tapscott S.J. Trinucleotide repeat expansion at the myotonic dystrophy locus reduces expression of DMAHP. Nat. Genet. 1997, 16:402-406.
117. Thornton C.A., Wymer J.P., Simmons Z., McClain C., Moxley R.T. Expansion of the myotonic dystrophy CTG repeat reduces expression of the flanking DMAHP gene. Nat. Genet. 1997, 16:407-409.
118. Korade-Mirnics Z., Tarleton J., Servidei S., Casey R.R., Gennarelli M., Pegoraro E., Angelini C., Hoffman E.P. Myotonic dystrophy: Tissue-specific effect of somatic CTG expansions on allele-specific DMAHP/SIX5 expression. Hum. Mol. Genet. 1999, 8:1017-1023.
119. Klesert T.R., Cho D.H., Clark J.I., Maylie J., Adelman J., Snider L., Yuen E.C., Soriano P., Tapscott S.J. Mice deficient in Six5 develop cataracts: Implications for myotonic dystrophy. Nat. Genet. 2000, 25:105-109.
120. Sarkar P.S., Appukuttan B., Han J., Ito Y., Ai C., Tsai W., Chai Y., Stout J.T., Reddy S. Heterozygous loss of Six5 in mice is sufficient to cause ocular cataracts. Nat. Genet. 2000, 25:110-114.
121. Alwazzan M., Newman E., Hamshere M.G., Brook J.D. Myotonic dystrophy is associated with a reduced level of RNA from the DMWD allele adjacent to the expanded repeat. Hum. Mol. Genet. 1999, 8:1491-1497.
122. Jansen G., Bachner D., Coerwinkel M., Wormskamp N., Hameister H., Wieringa B. Structural organization and developmental expression pattern of the mouse WD-repeat gene DMR-N9 immediately upstream of the myotonic dystrophy locus. Hum. Mol. Genet. 1995, 4:843-852.
123. Steinbach P., Glaser D., Vogel W., Wolf M., Schwemmle S. The DMPK gene of severely affected myotonic dystrophy patients is hypermethylated proximal to the largely expanded CTG repeat. Am. J. Hum. Genet. 1998, 62:278-285.
124. Usuki F., Ishiura S., Saitoh N., Sasagawa N., Sorimachi H., Kuzume H., Maruyama K., Terao T., Suzuki K. Expanded CTG repeats in myotonin protein kinase suppresses myogenic differentiation. Neuro Report 1997, 8:3749-3753.
125. Amack J.D., Mahadevan M.S. The myotonic dystrophy expanded CUG repeat tract is necessary but not sufficient to disrupt C2C12 myoblast differentiation. Hum. Mol. Genet. 2001, 10:1879-1887.
126. n repeats markedly inhibit differentiation of the C2C12 myoblast cell line: Implications for congenital myotonic dystrophy. Biochim. Biophys. Acta 1999, 1453:221-229.
127. Sasagawa N., Takahashi N., Suzuki K., Ishiura S. An expanded CTG trinucleotide repeat causes trans RNA interference: A new hypothesis for the pathogenesis of myotonic dystrophy. Biochem. Biophys. Res. Commun. 1999, 264:76-80.
128. Mankodi A., Logigian E., Callahan L., McClain C., White R., Henderson D., Krym M., Thornton C.A. Myotonic dystrophy in transgenic mice expressing an expanded CUG repeat. Science 2000, 289:1769-1773.
129. n triplet repeat RNA-binding protein and its expression in myotonic dystrophy. Nucleic Acids Res. 1996, 24:4407-4414.
130. Timchenko L.T., Timchenko N.A., Caskey C.T., Roberts R. Novel proteins with binding specificity for DNA CTG repeats and RNA CUG repeats: Implications for myotonic dystrophy. Hum. Mol. Genet. 1996, 5:115-121.
131. Timchenko N.A., Cai Z.J., Welm A.L., Reddy S., Ashizawa T., Timchenko L.T. RNA CUG repeats sequester CUGBP1 and alter protein levels and activity of CUGBP1. J. Biol. Chem. 2001, 267:7820-7826.
132. Timchenko N.A., Iakova P., Cai Z.J., Smith J.R., Timchenko L.T. Molecular basis for impaired muscle differentiation in myotonic dystrophy. Mol. Cell. Biol. 2001, 21:6927-6938.
133. Timchenko N.A., Wang G.L., Timchenko L.T. RNA CUG-binding protein 1 increases translation of 20-kDa isoform of CCAAT/enhancer-binding protein beta by interacting with the alpha and beta subunits of eukaryotic initiation translation factor 2. J. Biol. Chem. 2005, 280:20549-20557.
134. Timchenko N.A., Welm A.L., Lu X., Timchenko L.T. CUG repeat binding protein (CUGBP1) interacts with the 5? region of C/EBPbeta mRNA and regulates translation of C/EBPbeta isoforms. Nucleic Acids Res. 1999, 27:4517-4525.
135. n expansions associated with myotonic dystrophy. EMBO J. 2000, 19:4439-4448.
136. Fardaei M., Larkin K., Brook J.D., Hamshere M.G. In vivo co-localisation of MBNL protein with DMPK expanded-repeat transcripts. Nucleic Acids Res. 2001, 29:2766-2771.
137. Dansithong W., Paul S., Comai L., Reddy S. MBNL1 is the primary determinant of focus formation and aberrant insulin receptor splicing in DM1. J. Biol. Chem. 2005, 280:5773-5780.
138. Ho T.H., Charlet B.N., Poulos M.G., Singh G., Swanson M.S., Cooper T.A. Muscleblind proteins regulate alternative splicing. EMBO J. 2004, 23:3103-3112.
139. Ho T.H., Savkur R.S., Poulos M.G., Mancini M.A., Swanson M.S., Cooper T.A. Colocalization of muscleblind with RNA foci is separable from mis-regulation of alternative splicing in myotonic dystrophy. J. Cell. Sci. 2005, 118:2923-2933.
140. Mankodi A., Urbinati C.R., Yuan Q.P., Moxley R.T., Sansone V., Krym M., Henderson D., Schalling M., Swanson M.S., Thornton C.A. Muscleblind localizes to nuclear foci of aberrant RNA in myotonic dystrophy types 1 and 2. Hum. Mol. Genet. 2001, 10:2165-2170.
141. Mankodi A., Teng-Umnuay P., Krym M., Henderson D., Swanson M., Thornton C.A. Ribonuclear inclusions in skeletal muscle in myotonic dystrophy types 1 and 2. Ann. Neurol. 2003, 54:760-768.
142. Kanadia R.N., Johnstone K.A., Mankodi A., Lungu C., Thornton C.A., Esson D., Timmers A.M., Hauswirth W.W., Swanson M.S. A muscleblind knockout model for myotonic dystrophy. Science 2003, 302:1978-1980.
143. Philips A.V., Timchenko L.T., Cooper T.A. Disruption of splicing regulated by a CUG-binding protein in myotonic dystrophy. Science 1998, 280:737-741.
144. Savkur R.S., Philips A.V., Cooper T.A. Aberrant regulation of insulin receptor alternative splicing is associated with insulin resistance in myotonic dystrophy. Nat. Genet. 2001, 29:40-47.
145. Mankodi A., Takahashi M.P., Jiang H., Beck C.L., Bowers W.J., Moxley R.T., Cannon S.C., Thornton C.A. Expanded CUG repeats trigger aberrant splicing of ClC-1 chloride channel pre-mRNA and hyperexcitability of skeletal muscle in myotonic dystrophy. Mol. Cell 2002, 10:35-44.
146. Charlet B.N., Savkur R.S., Singh G., Philips A.V., Grice E.A., Cooper T.A. Loss of the muscle-specific chloride channel in type 1 myotonic dystrophy due to misregulated alternative splicing. Mol. Cell 2002, 10:45-53.
147. Berg J., Jiang H., Thornton C.A., Cannon S.C. Truncated ClC-1 mRNA in myotonic dystrophy exerts a dominant-negative effect on the Cl current. Neurology 2004, 63:2371-2375.
148. Sergeant N., Sablonniere B., Schraen-Maschke S., Ghestem A., Maurage C.A., Wattez A., Vermersch P., Delacourte A. Dysregulation of human brain microtubule-associated tau mRNA maturation in myotonic dystrophy type 1. Hum. Mol. Genet. 2001, 10:2143-2155.
149. Jiang H., Mankodi A., Swanson M.S., Moxley R.T., Thornton C.A. Myotonic dystrophy type 1 is associated with nuclear foci of mutant RNA, sequestration of muscleblind proteins and deregulated alternative splicing in neurons. Hum. Mol Genet. 2004, 13:3079-3088.
150. Wang Y., Wang J., Gao L., Lafyatis R., Stamm S., Andreadis A. Tau exons 2 and 10, which are misregulated in neurodegenerative diseases, are partly regulated by silencers which bind a SRp30c.SRp55 complex that either recruits or antagonizes htra2beta1. J. Biol. Chem. 2005, 280:14230-14239.
151. Buj-Bello A., Furling D., Tronchere H., Laporte J., Lerouge T., Butler-Browne G.S., Mandel J.L. Muscle-specific alternative splicing of myotubularin-related 1 gene is impaired in DM1 muscle cells. Hum. Mol. Genet. 2002, 11:2297-2307.
152. 2+-ATPase in myotonic dystrophy type 1. Hum. Mol. Genet. 2005, 14:2189-2200.
153. Savkur R.S., Philips A.V., Cooper T.A., Dalton J.C., Moseley M.L., Ranum L.P., Day J.W. Insulin receptor splicing alteration in myotonic dystrophy type 2. Am. J. Hum. Genet. 2004, 74:1309-1313.
154. Ebralidze A., Wang Y., Petkova V., Ebralidse K., Junghans R.P. RNA leaching of transcription factors disrupts transcription in myotonic dystrophy. Science 2004, 303:383-387.
155. Timchenko L.T., Iakova P., Welm A.L., Cai Z.J., Timchenko N.A. Calreticulin interacts with C/EBPalpha and C/EBPbeta mRNAs and represses translation of C/EBP proteins. Mol. Cell. Biol. 2002, 22:7242-7257.
156. Timchenko N.A., Patel R., Iakova P., Cai Z.J., Quan L., Timchenko L.T. Overexpression of CUG triplet repeatbinding protein, CUGBP1, in mice inhibits myogenesis. J. Biol. Chem. 2004, 279:13129-13139.
157. Kim D.H., Langlois M.A., Lee K.B., Riggs A.D., Puymirat J., Rossi J.J. HnRNP H inhibits nuclear export of mRNA containing expanded CUG repeats and a distal branch point sequence. Nucleic Acids Res. 2005, 33:3866-3874.
158. Wansink D.G., Wieringa B. Transgenic mouse models for myotonic dystrophy type 1 (DM1). Cytogenet. Genome. Res. 2003, 100:230-242.
159. Chen W., Liang Y., Deng W., Shimizu K., Ashique A.M., Li E., Li Y.P. The zinc-finger protein CNBP is required for forebrain formation in the mouse. Development 2003, 130:1367-1379.
160. Houseley J.M., Wang Z., Brock G.J., Soloway J., Artero R., Perez-Alonso M., O'Dell K.M., Monckton D.G. Myotonic dystrophy associated expanded CUG repeat muscleblind positive ribonuclear foci are not toxic to Drosophila. Hum. Mol. Genet. 2005, 14:873-883.
161. Koob M.D., Moseley M.L., Schut L.J., Benzow K.A., Bird T.D., Day J.W., Ranum L.P. An untranslated CTG expansion causes a novel form of spinocerebellar ataxia (SCA8). Nat. Genet. 1999, 21:379-384.